YUAN Ming, LIU Ya, DAI Chun. Correlation of systemic immune-inflammation index with hypoproteinemia in immunoglobulin A nephrology patients[J]. Journal of Clinical Medicine in Practice, 2022, 26(11): 127-132. DOI: 10.7619/jcmp.20214452
Citation: YUAN Ming, LIU Ya, DAI Chun. Correlation of systemic immune-inflammation index with hypoproteinemia in immunoglobulin A nephrology patients[J]. Journal of Clinical Medicine in Practice, 2022, 26(11): 127-132. DOI: 10.7619/jcmp.20214452

Correlation of systemic immune-inflammation index with hypoproteinemia in immunoglobulin A nephrology patients

More Information
  • Received Date: November 11, 2021
  • Available Online: June 01, 2022
  • Objective 

    To investigate the relationship between systemic immune inflammatory index (SII) and hypoalbuminemia in patients with immunoglobulin A nephropathy (IgAN).

    Methods 

    A total of 143 patients with IgAN were selected as study objects. According to whether serum albumin was more than 35 g/L or not, the patients were divided into hypoalbuminemia group and normal group. The SII level (SII=platelet×neutrophils/lymphocytes) and clinical data of the two groups were compared. According to the median SII, these 143 patients were divided into low SII group and high SII group, and clinical data of the two groups were compared. Logistic regression analysis was used to explore the risk factors of hypoproteinemia in patients with IgAN, and Spearman correlation analysis was used to analyze the correlations of related indexes with serum albumin.

    Results 

    There were 35 of 143 patients with hypoproteinemia (24.48%). Age, proportion of patients with pathological classification of E1, leukocyte, neutrophil, platelet, total cholesterol, 24-hour urinary protein quantity (24 hUTP), low density lipoprotein, SII, platelet to lymphocyte ratio (PLR) and neutrophil to lymphocyte ratio (NLR) in the hypoproteinemia group were higher than those in the normal group, while the levels of hemoglobin, albumin and estimated glomerular filtration rate (eGFR) were lower than those in the normal group, and the differences were statistically significant (P < 0.05). Age, levels of leukocyte, neutrophils, platelets, 24 hUTP, total cholesterol, PLR and NLR in the high SII group were higher than those in the low SII group, albumin, eGFR level and the proportions of patients with pathological type of T0 were lower than those in the low SII group, and the proportion of patients with pathological types of E1 and T1 to T2 was higher than that in the low SII group(P < 0.05). The results of correlation analysis showed that serum albumin was negatively correlated with SII, PLR, and neutrophils (P < 0.05), and positively correlated with creatinine (P < 0.05); multiple Logistic regression analysis showed that older age (OR=1.060, 95%CI, 1.012 to 1.101, P=0.013), low level of eGFR (OR=0.974, 95%CI, 0.953 to 0.996, P=0.019), and high level of SII (OR=1.001, 95%CI, 1.000 to 1.003, P=0.028) were independent risk factors for occurrence of hypoalbuminemia in IgAN patients.

    Conclusion 

    High level of SII is an independent risk factor for hypoalbuminemia in patients with IgAN. In clinical practice, the disease progression can be judged by monitoring the SII level, so that measures can be taken in advance to prevent the occurrence of hypoalbuminemia in patients with IgAN.

  • [1]
    MORIYAMA T. Clinical and histological features and therapeutic strategies for IgA nephropathy[J]. Clin Exp Nephrol, 2019, 23(9): 1089-1099. doi: 10.1007/s10157-019-01735-4
    [2]
    LE W B, LIANG S S, HU Y L, et al. Long-term renal survival and related risk factors in patients with IgA nephropathy: results from a cohort of 1155 cases in a Chinese adult population[J]. Nephrol Dial Transplant, 2011, 27(4): 1479-1485.
    [3]
    GOTO M, WAKAI K J, KAWAMURA T, et al. A scoring system to predict renal outcome in IgA nephropathy: a nationwide 10-year prospective cohort study[J]. Nephrol Dial Transplant, 2009, 24(10): 3068-3074. doi: 10.1093/ndt/gfp273
    [4]
    BERTHOUX F, MOHEY H, LAURENT B, et al. Predicting the risk for dialysis or death in IgA nephropathy[J]. J Am Soc Nephrol, 2011, 22(4): 752-761. doi: 10.1681/ASN.2010040355
    [5]
    DE FEO P, HORBER F F, HAYMOND M W. Meal stimulation of albumin synthesis: a significant contributor to whole body protein synthesis in humans[J]. Am J Physiol, 1992, 263(4 Pt 1): E794-E799.
    [6]
    KEANE W F, BRENNER B M, DE ZEEUW D, et al. The risk of developing end-stage renal disease in patients with type 2 diabetes and nephropathy: the RENAAL study[J]. Kidney Int, 2003, 63(4): 1499-1507. doi: 10.1046/j.1523-1755.2003.00885.x
    [7]
    XIE J Y, KIRYLUK K, WANG W M, et al. Predicting progression of IgA nephropathy: new clinical progression risk score[J]. PLoS One, 2012, 7(6): e38904. doi: 10.1371/journal.pone.0038904
    [8]
    YANG R N, CHANG Q, MENG X C, et al. Prognostic value of Systemic immune-inflammation index in cancer: a meta-analysis[J]. J Cancer, 2018, 9(18): 3295-3302. doi: 10.7150/jca.25691
    [9]
    CHEN J B, TANG R, ZHONG Y, et al. Systemic immune-inflammation index predicts a reduced risk of end-stage renal disease in Chinese patients with myeloperoxidase-anti-neutrophil cytoplasmic antibody-associated vasculitis: a retrospective observational study[J]. Exp Ther Med, 2021, 22(3): 989. doi: 10.3892/etm.2021.10421
    [10]
    ROLLINO C, VISCHINI G, COPPO R. IgA nephropathy and infections[J]. J Nephrol, 2016, 29(4): 463-468. doi: 10.1007/s40620-016-0265-x
    [11]
    STAPLES A O, GREENBAUM L A, SMITH J M, et al. Association between clinical risk factors and progression of chronic kidney disease in children[J]. Clin J Am Soc Nephrol, 2010, 5(12): 2172-2179. doi: 10.2215/CJN.07851109
    [12]
    TANGRI N, STEVENS L A, GRIFFITH J, et al. A predictive model for progression of chronic kidney disease to kidney failure[J]. JAMA, 2011, 305(15): 1553-1559. doi: 10.1001/jama.2011.451
    [13]
    SAKAI H. Cellular immunoregulatory aspects of IgA nephropathy[J]. Am J Kidney Dis, 1988, 12(5): 430-432. doi: 10.1016/S0272-6386(88)80040-4
    [14]
    LI Q Q, CHEN P, SHI S F, et al. Neutrophil-to-lymphocyte ratio as an independent inflammatory indicator of poor prognosis in IgA nephropathy[J]. Int Immunopharmacol, 2020, 87: 106811. doi: 10.1016/j.intimp.2020.106811
    [15]
    CHANG D, CHENG Y C, LUO R, et al. The prognostic value of platelet-to-lymphocyte ratio on the long-term renal survival in patients with IgA nephropathy[J]. Int Urol Nephrol, 2021, 53(3): 523-530. doi: 10.1007/s11255-020-02651-3
    [16]
    张春雷, 李欣蓉, 曾学辉, 等. 炎症介质在IgA肾病中的临床应用价值探讨[J]. 免疫学杂志, 2018, 34(4): 348-352. https://www.cnki.com.cn/Article/CJFDTOTAL-MYXZ201804014.htm
    [17]
    BAEK J E, CHANG J W, MIN W K, et al. Serum high-sensitivity C-reactive protein is not increased in patients with IgA nephropathy[J]. Nephron Clin Pract, 2008, 108(1): c35-c40.
    [18]
    曹月婷, 刘贵朋. 凝血指标、炎症因子和糖类抗原125在子宫内膜异位症诊断与分期评估中的应用价值[J]. 实用临床医药杂志, 2019, 23(3): 88-92. doi: 10.7619/jcmp.201903024
    [19]
    DOLSEN M R, CROSSWELL A D, PRATHER A A. Links between stress, sleep, and inflammation: are there sex differences?[J]. Curr Psychiatry Rep, 2019, 21(2): 8. doi: 10.1007/s11920-019-0993-4
    [20]
    WU H J, LAI C F, CHANG-PANESSO M, et al. Proximal tubule translational profiling during kidney fibrosis reveals proinflammatory and long noncoding RNA expression patterns with sexual dimorphism[J]. J Am Soc Nephrol, 2020, 31(1): 23-38. doi: 10.1681/ASN.2019040337
    [21]
    DE GIORGI U, PROCOPIO G, GIANNARELLI D, et al. Association of systemic inflammation index and body mass index with survival in patients with renal cell cancer treated with nivolumab[J]. Clin Cancer Res, 2019, 25(13): 3839-3846. doi: 10.1158/1078-0432.CCR-18-3661
    [22]
    HAO N, CHENG B C, YANG H T, et al. Time-varying serum albumin levels and all-cause mortality in prevalent peritoneal dialysis patients: a 5-year observational study[J]. BMC Nephrol, 2019, 20(1): 254. doi: 10.1186/s12882-019-1433-8
    [23]
    SOETERS P B, WOLFE R R, SHENKIN A. Hypoalbuminemia: pathogenesis and clinical significance[J]. JPEN J Parenter Enteral Nutr, 2019, 43(2): 181-193. doi: 10.1002/jpen.1451
    [24]
    POZZI C. Treatment of IgA nephropathy[J]. J Nephrol, 2016, 29(1): 21-25. doi: 10.1007/s40620-015-0248-3
  • Related Articles

    [1]LI Yang, JIANG Lifeng, SUN Xu, LIU Huaimin. Research progress of immune checkpoint inhibitors based biotherapeutics in epidermal growth factor receptor mutant of non-small cell lung cancer[J]. Journal of Clinical Medicine in Practice, 2022, 26(2): 142-148. DOI: 10.7619/jcmp.20214607
    [2]HU Jing. Study on the changes of immune cell function in children with Mycoplasmal pneumoniae pneumonia[J]. Journal of Clinical Medicine in Practice, 2020, 24(22): 60-62. DOI: 10.7619/jcmp.202022017
    [3]WANG Qian, SHEN Lijuan, GUAN Yunyan. Effect of immune-type enteral nutrition support on immune function of severe patients in ICU[J]. Journal of Clinical Medicine in Practice, 2017, (15): 71-73,77. DOI: 10.7619/jcmp.201715019
    [4]LI Shaoxing. Effect of different surgical treatment on immune function of patients with benign ovarian tumor[J]. Journal of Clinical Medicine in Practice, 2017, (5): 93-96. DOI: 10.7619/jcmp.201705026
    [5]ZHU Xuemei. Effect of diet nursing intervention on nutritional index and immune function of patients with gastric cancer after radical operation[J]. Journal of Clinical Medicine in Practice, 2016, (18): 73-75. DOI: 10.7619/jcmp.201618024
    [6]YANG Xianghong, LI Yanli, LUO Chunyu. Changes of immune function in children with mycoplasma pneumoniae pneumonia and its relationship with disease degrees and staging[J]. Journal of Clinical Medicine in Practice, 2016, (7): 113-116. DOI: 10.7619/jcmp.201607033
    [7]LI Xiuling. Effect of laparoscopic hysterectomy on ovarian function and immune function[J]. Journal of Clinical Medicine in Practice, 2016, (7): 93-95,108. DOI: 10.7619/jcmp.201607027
    [8]JIA Haiying. Effect of oral probiotics on treatment of neonates with hyperbilirubinemia and its influence on immune function[J]. Journal of Clinical Medicine in Practice, 2015, (7): 104-106. DOI: 10.7619/jcmp.201507030
    [9]SHI Xufeng, XU Fei. Efficacy of laparoscopic radical operation for gastric cancer and its influence on the immune function[J]. Journal of Clinical Medicine in Practice, 2014, (13): 133-134,137. DOI: 10.7619/jcmp.201413045
    [10]ZHANG Yumei, WANG Jiaxiao. Influence of ginsenoside Rg3 on proliferation of Lewis lung cancer cells in vitro and immune function of tumor-bearing mice[J]. Journal of Clinical Medicine in Practice, 2014, (1): 5-8. DOI: 10.7619/jcmp.201401002
  • Cited by

    Periodical cited type(2)

    1. 代莉亚,王晓英,梁利杰. 1M3S护理管理模式对原发性肝癌手术患者手术结局、术后肠道微生态分布及免疫功能的影响. 国际护理学杂志. 2023(15): 2808-2811 .
    2. 曲畅. 基于品管圈活动的三维质控护理对重症急性胰腺炎血液滤过患者生活质量及并发症的影响. 吉林医学. 2023(12): 3540-3543 .

    Other cited types(0)

Catalog

    Article views (244) PDF downloads (22) Cited by(2)

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return